Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank71
5Y CAGR-48.9%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
-48.9%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202571.72%
2024318.72%
2023-46.11%
2022-28.04%
202120.47%
20202049.76%
201998.79%
2018-99.93%
2017-9.82%
201613.12%